You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCLC Stage C

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Liquid Biopsy
  • (no location specified)
Apr 18, 2023

HCC Trial in China (DEB-TACE and HAIC, DEB-TACE)

Recruiting
  • HCC
  • DEB-TACE and HAIC
  • DEB-TACE
  • Luohe, Henan, China
  • +15 more
Mar 28, 2023

BCLC Stage C Hepatocellular Carcinoma Trial in Hangzhou (TACE, Tilelizumab, Sorafenib)

Not yet recruiting
  • BCLC Stage C Hepatocellular Carcinoma
  • TACE
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Aug 10, 2021

Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

Terminated
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib S-malate
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • +3 more
  • Resin microspheres containing yttrium-90 (Y-90)
  • Mission Hills, California
  • +15 more
Sep 15, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +9 more
  • Durvalumab
  • Tremelimumab
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in

Recruiting
  • BCLC Stage A Hepatocellular Carcinoma
  • +3 more
  • 18F-Fluoromisonidazole
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
May 25, 2022

Advanced Adult Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Recurrent Adult Hepatocellular Carcinoma Trial

Completed
Has Results
  • Advanced Adult Hepatocellular Carcinoma
  • +10 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Not yet recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +10 more
  • Ipilimumab
  • Nivolumab
  • Miami, Florida
  • +4 more
Aug 23, 2022

Unresectable Hepatocellular Carcinoma Trial (Donafenib plus Sintilimab in combination with transarterial chemoembolisation)

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • Donafenib plus Sintilimab in combination with transarterial chemoembolisation
  • (no location specified)
Aug 17, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab; Bevacizumab Biosimilar)

Recruiting
  • Hepatocellular Carcinoma
  • Sintilimab; Bevacizumab Biosimilar
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 25, 2021

Hepatocellular Carcinoma Trial in Shanghai (TACE combined with Camrelizumab, TACE plus Camrelizumab)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • TACE combined with Camrelizumab
  • TACE plus Camrelizumab
  • Shanghai, Shanghai, China
    Department of Interventional Radiology, Zhongshan Hospital, Fuda
Sep 23, 2021

Transarterial Chemoembolization, Hepatocellular Carcinoma Trial (cTACE-HAIC)

Unknown status
  • Transarterial Chemoembolization
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 17, 2020

Hepatocellular Carcinoma Trial in Wuhan (TACE+Lenvatininb+Camrelizumab)

Recruiting
  • Hepatocellular Carcinoma
  • TACE+Lenvatininb+Camrelizumab
  • Wuhan, Hubei, China
    Wuhan Union Hospital
May 27, 2021

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

Not yet recruiting
  • Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • Atezolizumab Injection
  • +2 more
  • (no location specified)
Mar 16, 2023

Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Bevacizumab Biosimilar QL 1101
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 20, 2023

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Adult Hepatocellular Carcinoma Trial in

Completed
  • Adult Primary Hepatocellular Carcinoma
  • +4 more
  • Chinese herbal formulation PHY906
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 26, 2021

C-staged Hepatocellular Carcinoma in BCLC Classification Trial in Guangzhou, Guanzhou, Changsha (Hepatic Arterial Infusion

Recruiting
  • C-staged Hepatocellular Carcinoma in BCLC Classification
  • Hepatic Arterial Infusion combined with Apatinib and Camrelizumab
  • Apatinib combined with Camrelizumab
  • Guangzhou, Guangdong, China
  • +4 more
Jun 15, 2022

Hepatocellular Carcinoma Trial in Guangzhou (PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 inhibitor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 21, 2021

C-staged Hepatocellular Carcinoma in BCLC Classification Trial in Guangzhou (Hepatic Arterial Infusion combined with Apatinib

Recruiting
  • C-staged Hepatocellular Carcinoma in BCLC Classification
  • Hepatic Arterial Infusion combined with Apatinib and Camrelizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 3, 2022

Hepatocellular Carcinoma Trial in Shanghai (PD-1 and Lenvatinib Plus TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 and Lenvatinib Plus TACE
  • Shanghai, Shanghai, China
    Huashan hospital
Aug 16, 2022

Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Rennes, France
    Centre Eugene Marquis
Jan 16, 2023

Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and

Not yet recruiting
  • Hepatocellular Carcinoma
  • Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
  • Atezolizumab and bevacizumab
  • transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022